T. Utkan Et Al. , "Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes," CURRENT NEUROVASCULAR RESEARCH , vol.12, pp.135-146, 2015
Utkan, T. Et Al. 2015. Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes. CURRENT NEUROVASCULAR RESEARCH , vol.12 , 135-146.
Utkan, T., Yazır, Y., Karson, A., & Bayramgürler, D., (2015). Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes. CURRENT NEUROVASCULAR RESEARCH , vol.12, 135-146.
Utkan, TİJEN Et Al. "Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes," CURRENT NEUROVASCULAR RESEARCH , vol.12, 135-146, 2015
Utkan, TİJEN Et Al. "Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes." CURRENT NEUROVASCULAR RESEARCH , vol.12, pp.135-146, 2015
Utkan, T. Et Al. (2015) . "Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes." CURRENT NEUROVASCULAR RESEARCH , vol.12, pp.135-146.
@article{article, author={TİJEN UTKAN Et Al. }, title={Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin-induced Diabetes}, journal={CURRENT NEUROVASCULAR RESEARCH}, year=2015, pages={135-146} }